Introducing heat-not-burn tobacco improves hematocrit and cigarette smoking-related symptoms in patients with smokers’ polycythemia and polycythemia vera
PLOS One · 2025
DOI: 10.1371/journal.pone.0323437 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Kazuhide Iizuka und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Laboratory Medicine, Department of Pathology and Microbiology, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan. Hauptthemen laut MEDLINE: Polycythemia, Polycythemia Vera, Cigarette Smoking, Smoking Cessation. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI, Kaltech Corporation.
Abstract (Originalsprache)
Cigarette smoking induces relative and absolute erythrocytosis (smokers’ polycythemia). In patients with smokers’ polycythemia complicated by chronic obstructive pulmonary disease, the incidence and mortality rate of pulmonary embolism increase. Therefore, improving erythrocytosis by smoking cessation is important; however, smoking cessation is often difficult to achieve. This study investigated the influence of introducing heat-not-burn tobacco in patients with smokers’ polycythemia. Fifteen smokers with erythrocytosis were diagnosed with smokers’ polycythemia (n = 13) or polycythemia vera (n = 2) groups. The patients selected a switch to heat-not-burn (HNB) tobacco or smoking cessation, and the subsequent changes in hematological data and symptoms were evaluated. Eight patients with smokers’ polycythemia and two with polycythemia vera selected a switch to HNB tobacco, and the other five patients with smokers’ polycythemia selected smoking cessation. In both the HNB tobacco and smoking cessation groups, all patients showed improved hematocrit (Hct) and sputum volume and ameliorated numbness, headache, and vertigo. In the patients with smokers’ polycythemia, Hct of the HNB tobacco group was equivalent to that in the patients with smoking cessation group (47.51 ± 3.48% vs. 45.63 ± 2.79%, P = 0.605). Introduction of HNB tobacco may be useful for reducing erythrocytosis in smokers for whom smoking cessation is difficult.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Laboratory Medicine, Department of Pathology and Microbiology, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan.
- Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan.
- Division of Hematology, Tokoro Memorial Hospital, Atami city, Shizuoka, Japan.
- Department of Hematology, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan.
- Pharmaessentia Japan KK, Minato-ku, Tokyo, Japan.
ORCID-Profile: Kazuhide Iizuka
Förderung
- JSPS KAKENHI
- Kaltech Corporation
Zitieren
APA
Iizuka, K., Iizuka, Y., Ito, S., Endo, T., Nukariya, H., Takeuchi, Y., Koike, T., Kurihara, K., Takahashi, H., Nakagawa, M., Hamada, T., Ohtake, S., Iriyama, N., Miura, K., Nakayama, T., Hatta, Y., Nakamura, H., & Komatsu, N. (2025). Introducing heat-not-burn tobacco improves hematocrit and cigarette smoking-related symptoms in patients with smokers’ polycythemia and polycythemia vera. PLOS One. https://doi.org/10.1371/journal.pone.0323437
Vancouver
Iizuka K, Iizuka Y, Ito S, Endo T, Nukariya H, Takeuchi Y, et al. Introducing heat-not-burn tobacco improves hematocrit and cigarette smoking-related symptoms in patients with smokers’ polycythemia and polycythemia vera. PLOS One. 2025. doi:10.1371/journal.pone.0323437
BibTeX
@article{Iizuka2025,
author = {Iizuka, Kazuhide and Iizuka, Yoshikazu and Ito, Shun and Endo, Toshihide and Nukariya, Hironao and Takeuchi, Yuichi and Koike, Takashi and Kurihara, Kazuya and Takahashi, Hiromichi and Nakagawa, Masaru and Hamada, Takashi and Ohtake, Shimon and Iriyama, Noriyoshi and Miura, Katsuhiro and Nakayama, Tomohiro and Hatta, Yoshihiro and Nakamura, Hideki and Komatsu, Norio},
title = {Introducing heat-not-burn tobacco improves hematocrit and cigarette smoking-related symptoms in patients with smokers’ polycythemia and polycythemia vera},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0323437}
}
EUVIMED